183 related articles for article (PubMed ID: 27559841)
1. Effects of Miconazole Oral Gel on Blood Concentrations of Tacrolimus and Cyclosporine: A Retrospective Observational Study.
Ishiwata Y; Nagata M; Arai T; Makiishi M; Yoshikawa M; Takahashi H; Kohsaka H; Yasuhara M
Ther Drug Monit; 2016 Dec; 38(6):717-721. PubMed ID: 27559841
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy.
Nakamura Y; Takeuchi H; Okuyama K; Akashi T; Jojima Y; Konno O; Akashi I; Hama K; Iwahori T; Ashizawa T; Hirano T; Oka K; Matsuno N; Nagao T
Transplant Proc; 2005 May; 37(4):1725-7. PubMed ID: 15919445
[TBL] [Abstract][Full Text] [Related]
3. Optimal dose and target trough level in cyclosporine and tacrolimus conversion in renal transplantation as evaluated by lymphocyte drug sensitivity and pharmacokinetic parameters.
Takeuchi H; Okuyama K; Konno O; Jojima Y; Akashi I; Nakamura Y; Iwamoto H; Hama K; Iwahori T; Uchiyama M; Ashizawa T; Matsuno N; Nagao T; Hirano T; Oka K
Transplant Proc; 2005 May; 37(4):1745-7. PubMed ID: 15919452
[TBL] [Abstract][Full Text] [Related]
4. Evidence of different pharmacokinetics including relationship among AUC, peak, and trough levels between cyclosporine and tacrolimus in renal transplant recipients using new pharmacokinetic parameter--why cyclosporine is monitored by C(2) level and tacrolimus by trough level--.
Takeuchi H; Matsuno N; Senuma K; Hirano T; Yokoyama T; Taira S; Kihara Y; Kuzuoka K; Konno O; Jojima Y; Mejit A; Akashi I; Nakamura Y; Iwamoto H; Hama K; Iwahori T; Ashizawa T; Nagao T; Toraishi T; Okuyama K; Oka K; Unezaki S
Biol Pharm Bull; 2008 Jan; 31(1):90-4. PubMed ID: 18175948
[TBL] [Abstract][Full Text] [Related]
5. Oseltamivir, an influenza neuraminidase inhibitor drug, does not affect the steady-state pharmacokinetic characteristics of cyclosporine, mycophenolate, or tacrolimus in adult renal transplant patients.
Lam H; Jeffery J; Sitar DS; Aoki FY
Ther Drug Monit; 2011 Dec; 33(6):699-704. PubMed ID: 22105586
[TBL] [Abstract][Full Text] [Related]
6. Evidence of different pharmacokinetics between cyclosporine and tacrolimus in renal transplant recipients: why cyclosporine is monitored by C2 level and tacrolimus by trough level.
Takeuchi H; Matsuno N; Hirano T; Toraishi T; Konno O; Nakamura Y; Iwamoto H; Hama K; Unezaki S; Nagao T
Transplant Proc; 2008 Sep; 40(7):2240-2. PubMed ID: 18790203
[TBL] [Abstract][Full Text] [Related]
7. Drug interactions and safety profiles with concomitant use of caspofungin and calcineurin inhibitors in allogeneic haematopoietic cell transplantation.
Nishimoto M; Koh H; Tokuwame A; Makuuchi Y; Kuno M; Takakuwa T; Okamura H; Koh S; Yoshimura T; Nanno S; Nakamae M; Hirose A; Nakashima Y; Nakane T; Hino M; Nakamae H
Br J Clin Pharmacol; 2017 Sep; 83(9):2000-2007. PubMed ID: 28407449
[TBL] [Abstract][Full Text] [Related]
8. Influence of azole antifungal drugs on blood tacrolimus levels after switching from intravenous tacrolimus to once-daily modified release tacrolimus in patients receiving allogeneic hematopoietic stem cell transplantation.
Mimura A; Yamaori S; Ikemura N; Katsuyama Y; Matsuzawa N; Ohmori S
J Clin Pharm Ther; 2019 Aug; 44(4):565-571. PubMed ID: 30950099
[TBL] [Abstract][Full Text] [Related]
9. Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants.
Nara M; Takahashi N; Miura M; Niioka T; Kagaya H; Fujishima N; Saitoh H; Kameoka Y; Tagawa H; Hirokawa M; Sawada K
Eur J Clin Pharmacol; 2013 Jun; 69(6):1321-9. PubMed ID: 23354810
[TBL] [Abstract][Full Text] [Related]
10. What is the calcineurin inhibitor of choice for pediatric renal transplantation?
Kari JA; Trompeter RS
Pediatr Transplant; 2004 Oct; 8(5):437-44. PubMed ID: 15367278
[TBL] [Abstract][Full Text] [Related]
11. The proton pump inhibitor lansoprazole, but not rabeprazole, the increased blood concentrations of calcineurin inhibitors in Japanese patients with connective tissue diseases.
Isoda K; Takeuchi T; Kotani T; Hirano-Kuwata S; Shoda T; Hata K; Yoshida S; Makino S; Hanafusa T
Intern Med; 2014; 53(13):1413-8. PubMed ID: 24990333
[TBL] [Abstract][Full Text] [Related]
12. Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients.
Falck P; Vethe NT; Asberg A; Midtvedt K; Bergan S; Reubsaet JL; Holdaas H
Nephrol Dial Transplant; 2008 Mar; 23(3):1048-53. PubMed ID: 17956893
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and Biodistribution of Tacrolimus after Topical Administration: Implications for Vascularized Composite Allotransplantation.
Feturi FG; Schnider JT; Fanzio PM; Erbas VE; Oksuz S; Sahin H; Dong L; Unadkat JM; Spiess AM; Plock JA; Solari MG; Gorantla VS; Venkataramanan R
Pharm Res; 2020 Oct; 37(11):222. PubMed ID: 33067715
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers.
Hulskotte E; Gupta S; Xuan F; van Zutven M; O'Mara E; Feng HP; Wagner J; Butterton J
Hepatology; 2012 Nov; 56(5):1622-30. PubMed ID: 22576324
[TBL] [Abstract][Full Text] [Related]
15. Modeling of Tacrolimus Exposure in Kidney Transplant According to Posttransplant Time Based on Routine Trough Concentration Data.
Ben Fredj N; Woillard JB; Debord J; Chaabane A; Boughattas N; Marquet P; Saint-Marcoux F; Aouam K
Exp Clin Transplant; 2016 Aug; 14(4):394-400. PubMed ID: 27506258
[TBL] [Abstract][Full Text] [Related]
16. Posttransplant Calcineurin Inhibitors Levels and Intrapatient Variability Are Not Associated With Long-term Outcomes Following Liver Transplantation.
Di Maira T; Sapisochin G; Lilly L; Fonés V; Berenguer M
Transplantation; 2020 Jun; 104(6):1201-1209. PubMed ID: 31609904
[TBL] [Abstract][Full Text] [Related]
17. Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus.
Garg V; van Heeswijk R; Lee JE; Alves K; Nadkarni P; Luo X
Hepatology; 2011 Jul; 54(1):20-7. PubMed ID: 21618566
[TBL] [Abstract][Full Text] [Related]
18. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus.
Sinha MD; MacLeod R; Rigby E; Clark AG
Nephrol Dial Transplant; 2006 Jul; 21(7):1848-54. PubMed ID: 16311257
[TBL] [Abstract][Full Text] [Related]
19. A Pilot Study of the Pharmacokinetics of the Modified-Release Once-Daily Tacrolimus Formulation Administered to Living-Donor Liver Transplant Recipients.
Song GW; Lee SG; Hwang S; Kim KH; Kim WJ; Sin MH; Yoon YI; Tak EY
Exp Clin Transplant; 2016 Aug; 14(4):412-8. PubMed ID: 26976646
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation.
Trompeter R; Filler G; Webb NJ; Watson AR; Milford DV; Tyden G; Grenda R; Janda J; Hughes D; Ehrich JH; Klare B; Zacchello G; Bjorn Brekke I; McGraw M; Perner F; Ghio L; Balzar E; Friman S; Gusmano R; Stolpe J
Pediatr Nephrol; 2002 Mar; 17(3):141-9. PubMed ID: 11956848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
